Heartsciences Inc (HSCS) Quarterly Institutional 13F Update (Q2 2026)

No AI summary for this filing type

No AI summary for this filing type

No AI summary for this filing type

AI summary pending

HeartSciences (HSCS) disclosed that on August 4, 2026, Nasdaq notified it of a continued listing deficiency: the company reported stockholders' equity of $226,060, below the $2.5 million minimum required by Nasdaq Listing Rule 5550(b)(1). Nasdaq has given the company 45 days, until September 18, 2026, to submit a compliance plan, with a possible extension to January 31, 2027 if the plan is accepted. There is no immediate impact on trading — the common stock and public warrants remain listed — and the company plans to base its compliance plan on its previously announced all-stock merger with Fortitude Mining Holdings, announced June 23, 2026.

HeartSciences Inc. issued a press release on July 29, 2026, disclosing its financial results for the fiscal year ended April 30, 2026, along with an update on its proposed all-stock merger with Fortitude Mining Holdings, a digital asset mining platform focused on Zcash. The press release is attached as an exhibit to this 8-K filing, but the filing itself does not contain specific financial numbers. The merger was previously announced on June 23, 2026.

HeartSciences Inc. (ticker: HSCS) filed an 8-K on July 27, 2026, announcing an amendment to its merger agreement with Fortitude Mining Holdings and its subsidiary. The amendment tweaks two specific areas: it clarifies how shareholders can redeem their shares under the new LLC structure, and it modifies the parent company's charter regarding how shareholders can act by written consent. This is a relatively minor update to the original merger agreement signed in June, and full details are expected in the upcoming proxy statement.

HeartSciences Inc. (ticker: HSCS) filed an 8-K with financial statements related to its acquisition of Fortitude. The filing includes audited annual statements for Fortitude for 2025 and 2024, unaudited interim statements for Q1 2026 and 2025, and unaudited pro forma financials combining both companies. This is a routine disclosure to satisfy 8-K reporting requirements after closing an acquisition.

HeartSciences Inc. issued a press release on July 23, 2026, announcing the filing of its Annual Report on Form 10-K for the fiscal year ended April 30, 2026, and stating that it expects to soon file a preliminary proxy statement related to its previously announced merger transaction with Fortitude Mining Holdings and its subsidiaries. The press release was furnished under Regulation FD as Exhibit 99.1 to this Form 8-K, not as a filed document.

HeartSciences Inc. (HSCS) filed an 8-K on July 7, 2026, disclosing an unregistered sale of equity securities. The company is granting an equity award to certain officers and directors, with the issuance exempt from SEC registration under Section 4(a)(2) and Rule 506(b). Full details are incorporated by reference to Item 5.02 of the filing.